This inventor holds 1 USPTO granted patent. Top assignee: Japanese Foundation for Cancer Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Nobuhiko Gyobu: Innovator in Cancer Research
Introduction
Nobuhiko Gyobu is a prominent inventor based in Gifu, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies.
Latest Patents
Gyobu holds a patent for an anti-podoplanin antibody. The objective of this invention is to provide a humanized or mouse-human chimeric anti-podoplanin antibody or an antibody fragment containing the antigen-binding region. This invention is achieved by isolating a humanized or mouse-human chimeric anti-podoplanin antibody that comprises a predetermined amino acid sequence, or an antibody fragment containing the antigen-binding region.
Career Highlights
Nobuhiko Gyobu is associated with the Japanese Foundation for Cancer Research. His work focuses on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Gyobu collaborates with notable colleagues, including Naoya Fujita and Mamoru Kakino. Their combined expertise contributes to advancing research in the field of cancer treatment.
Conclusion
Nobuhiko Gyobu's contributions to cancer research through his patented innovations highlight his role as a key figure in the scientific community. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile